Medicine:Pegylated interferon

From HandWiki
Revision as of 00:02, 5 February 2024 by John Stpola (talk | contribs) (fixing)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012:[1]

In these formulations, Polyethylene glycol (PEG) is added to make interferon last longer in the body.[3] They are used to treat both hepatitis B,[4] hepatitis C[1] and multiple sclerosis.[2]

Pegylated interferon is contraindicated in patients with hyperbilirubinaemia.[citation needed]

References

  1. ↑ 1.0 1.1 editor, Emilio Jirillo (2008). Hepatitis C virus disease : immunobiology and clinical applications ([Online-Ausg.] ed.). New York: Springer. pp. 237. ISBN 978-0-387-71375-5. https://books.google.com/books?id=yjzazAgMWEUC&pg=PA237. 
  2. ↑ 2.0 2.1 Kieseier BC, Calabresi PA.; Calabresi (2012). "PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis". CNS Drugs 26 (3): 205–14. doi:10.2165/11596970-000000000-00000. PMID 22201341. http://adisonline.com/cnsdrugs/Abstract/2012/26030/PEGylation_of_Interferon___1a__A_Promising.2.aspx. 
  3. ↑ "Hepatology Focus: Update on Hepatitis C Treatment: Pegylated Interferon". February 15, 2001. http://www.medscape.com/viewarticle/407963_5. 
  4. ↑ Clinical Hepatology. [S.l.]: Springer Berlin Heidelberg. 2010. pp. 765. ISBN 978-3-642-04509-7. https://books.google.com/books?id=lrPX8C4p90QC&pg=PA765. 




Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Pegylated_interferon&oldid=3269017"